QuantaLife Unveils Digital PCR Platform; Offers Early Access Before '11 Full Commercial Launch

The platform, called the Digital Droplet PCR system, is currently in the hands of early-access users at undisclosed academic institutions, and QuantaLife is making it available to other interested parties at an initial cost of $50,000.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.